Quick disclosure first. I take Zepbound at 12.5mg, prescribed by my doctor and covered by insurance. If the coverage went away tomorrow I’d be on LillyDirect cash-pay before the end of the week. That’s where I’m coming from.
I admit I am fascinated by the rise of peptides. It’s as much a business story as a medical one, and the distribution channels are changing fast. I know a few folks who are into peptides and sometimes argue with them.
In my mind, part of being proactive about your health is deciding what meds, what sources, and what prices you’re comfortable with. That means actually knowing what the prices are. What struck me when I started running the numbers is that most of the threads I read are still arguing about a price gap that doesn’t really exist anymore.
Where the LillyDirect price actually sits in 2026
LillyDirect Zepbound vials are $299 for the 2.5mg starting dose, $399 for 5mg, and $449 for 7.5mg, 10mg, 12.5mg, and 15mg, assuming you stay in the journey program by refilling within 45 days. That’s the cash floor in April 2026, no insurance required.
It wasn’t always $449. Lilly cut prices repeatedly through late 2025 and early 2026 to compete with the compounded market. The FDA then closed most of the compounding loophole and Hims settled with Novo in March and Lilly in April. The branded price floor in 2026 is a different drug economy than the one most threads are still relitigating.
What the grey market actually costs
I won’t link to the vendor, but I pulled real pricing off a US peptide reseller. Tirzepatide 15mg vials at $130.99 each, dropping to $117.89 with the 10% bulk discount on orders of 20 or more. That works out to $7.86 per mg, if you can afford the $2,358 upfront.
Worth noting: these “research chem” vendors are US-based resellers that source bulk peptide from overseas, repackage it, and run some level of in-house or third-party testing before listing. That testing is part of what you’re paying for. Order direct from a Chinese manufacturer and you’re looking at something like $100 for a kit of 10 vials at 10mg, but that’s a whole different world in terms of risk. Scams, purity, legality. Probably little or no customer service. Customs risk is on you. TBH, I have zero direct insight into that channel and I’m not interested in acquiring any.
Retatrutide is a different conversation
It’s still in Phase 3 trials and there’s no legal way to get it outside an enrolled study. Anyone selling it is selling something the FDA has not approved at any dose, in any form, for any indication. I’m not running that math because I don’t think the comparison is honest.
Tirzepatide cost by weekly dose
The chart maps tirzepatide pricing across weekly doses. Grey market scales linearly with milligrams. LillyDirect flattens at $449 for any dose 7.5mg and up, which is what kills the grey market price advantage at the top end.
The crossover sits between 12.5mg and 15mg. By 15mg weekly, grey market runs about $472 a month versus $449 for LillyDirect. Branded is cheaper. Nobody on the affordability threads is saying that out loud.
What you’re paying for at LillyDirect
The trade you’re getting for the LillyDirect price is real. FDA oversight on identity, purity, and sterility. A drug that’s actually the dose on the label. A clinician in the loop. HSA and FSA eligibility. No customs risk. A recall mechanism if a batch goes bad.
Where I land
I’m on Zepbound at 12.5mg, prescribed by an actual physician, monitored with bloodwork, covered by insurance, and recallable if a batch goes wrong. I’d choose that over a grey market vial even when the math looks closer to favorable, which at my dose it doesn’t.
Call me a Big Pharma shill if you have to. As much as I don’t love pharma, I don’t love enriching some dude with a warehouse and a label maker who’s profiting off Lilly’s IP either. The oversight, the labeled dose, the recall mechanism, and the clinician in the loop are worth the premium to me. At maintenance doses the premium isn’t even that big anymore, and at the top dose, branded is the cheaper option.
The “branded is unaffordable” framing was maybe true in 2024. It isn’t true at maintenance doses now, and at the top dose the math has flipped. Worth at least using current numbers in the conversation.
Nothing in this post is medical advice. I’m not a clinician. If you’re considering a GLP-1, talk to your doctor about whether it’s right for you and how to access it safely.
I use Claude as a research and drafting tool. All opinions are mine.
Sources
- LillyDirect Zepbound pricing and Self Pay Journey Program terms: https://zepbound.lilly.com/savings
- Hims/Novo Nordisk GLP-1 deal (BioPharma Dive): https://www.biopharmadive.com/news/hims-novo-deal-obesity-drugs-wegovy-ozempic/814160/